InspireMD Inc Market Cap ($30.82 Million)
Market Cap & Net Worth: InspireMD Inc (NSPR)
InspireMD Inc market cap. InspireMD Inc (NASDAQ:NSPR) has a market capitalization of $30.82 Million ($30.82 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23459 globally and #5118 in its home market, demonstrating a 46.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InspireMD Inc's stock price $0.66 by its total outstanding shares 46838962 (46.84 Million). Also see InspireMD Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
InspireMD Inc Market Cap History (2015–2026)
InspireMD Inc market cap history from 2015 to 2026. Data shows change from $772.84 Billion to $30.82 Million (-61.71% CAGR). Check InspireMD Inc (NSPR) share price today for real-time trading data and today's change.
Index Memberships
InspireMD Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #661 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2194 of 3165 |
Weight: InspireMD Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InspireMD Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InspireMD Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore InspireMD Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.29x
InspireMD Inc's market cap is 9.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $87.82 Billion | $1.89 Million | -$8.46 Million | 46369.09x | N/A |
| 2017 | $4.57 Billion | $2.76 Million | -$8.44 Million | 1654.04x | N/A |
| 2018 | $5.62 Billion | $3.60 Million | -$7.24 Million | 1560.87x | N/A |
| 2019 | $758.79 Million | $3.72 Million | -$10.04 Million | 203.92x | N/A |
| 2020 | $238.88 Million | $2.48 Million | -$10.54 Million | 96.13x | N/A |
| 2021 | $141.45 Million | $4.50 Million | -$14.92 Million | 31.47x | N/A |
| 2022 | $40.28 Million | $5.17 Million | -$18.49 Million | 7.79x | N/A |
| 2023 | $131.62 Million | $6.21 Million | -$19.92 Million | 21.21x | N/A |
| 2024 | $123.19 Million | $7.01 Million | -$32.01 Million | 17.58x | N/A |
| 2025 | $83.37 Million | $8.98 Million | -$48.79 Million | 9.29x | N/A |
Competitor Companies of NSPR by Market Capitalization
Companies near InspireMD Inc in the global market cap rankings as of November 4, 2026. Also see InspireMD Inc assets under control for a full breakdown of the balance sheet.
Key companies related to InspireMD Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of InspireMD Inc (2015–2026)
Market capitalization of InspireMD Inc from 2015 to today. Between 2015 and today, InspireMD Inc's market cap moved from $772.84 Billion to $ 30.82 Million, with a yearly change of -61.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $30.82 Million | -63.04% |
| 2025 | $83.37 Million | -32.32% |
| 2024 | $123.19 Million | -6.41% |
| 2023 | $131.62 Million | +226.74% |
| 2022 | $40.28 Million | -71.52% |
| 2021 | $141.45 Million | -40.78% |
| 2020 | $238.88 Million | -68.52% |
| 2019 | $758.79 Million | -86.50% |
| 2018 | $5.62 Billion | +23.08% |
| 2017 | $4.57 Billion | -94.80% |
| 2016 | $87.82 Billion | -88.64% |
| 2015 | $772.84 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of InspireMD Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.82 Million USD |
| MoneyControl | $30.82 Million USD |
| MarketWatch | $30.82 Million USD |
| marketcap.company | $30.82 Million USD |
| Reuters | $30.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more